Issue 1/2015
Content (7 Articles)
Neurotrophin Family Members as Neuroprotectants in Retinal Degenerations
Edoardo Abed, Giovanni Corbo, Benedetto Falsini
Peptide-Based Vaccination and Induction of CD8+ T-Cell Responses Against Tumor Antigens in Breast Cancer
Michiko Harao, Elizabeth A. Mittendorf, Laszlo G. Radvanyi
Enzymes Approved for Human Therapy: Indications, Mechanisms and Adverse Effects
Brian A. Baldo
Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
K. P. Garnock-Jones
Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate Quality-Adjusted Life-Years
Luciana Scalone, Paolo A. Cortesi
Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs”
Federico Spandonaro, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Giampiero Girolomoni, Patrizia Martini, Andrea Peserico, Barbara Polistena, Antonio Puglisi Guerra, Gino Antonio Vena, Gianfranco Altomare, Piergiacomo Calzavara Pinton